QIAstat-Dx Respiratory SARS-CoV-2 Panel
Rapidly detect 20+ viral and bacterial respiratory targets, including SARS-CoV-2, to support confident diagnosis and treatment.
Receive your quote directly from the manufacturer.
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is a multiplex syndromic test designed for rapid, qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other common respiratory pathogens. It delivers actionable results directly from nasopharyngeal swabs, supporting fast clinical decision-making in acute care settings.
Comprehensive respiratory pathogen coverage
This cartridge-based panel simultaneously analyzes multiple viral and bacterial respiratory targets in a single run, reducing the need for sequential testing. Optimized assay design and integrated controls support reliable detection of SARS-CoV-2 alongside other respiratory pathogens that present with similar symptoms.
Streamlined workflow and rapid turnaround
The QIAstat-Dx Respiratory SARS-CoV-2 Panel is fully integrated with the QIAstat-Dx system, combining sample preparation, nucleic acid amplification and detection in one closed cartridge. Minimal hands-on time and an intuitive interface help laboratories and clinical facilities standardize workflows and deliver consistent results within a short turnaround time.
Designed for clinical decision support
By providing qualitative results for multiple respiratory pathogens from a single sample, the panel supports differential diagnosis and helps guide isolation, treatment and infection control strategies. The standardized format and automated processing make it suitable for routine use in hospital, emergency and reference laboratory environments.
Key features and benefits of QIAstat-Dx Respiratory SARS-CoV-2 Panel:
- Multiplex syndromic panel for qualitative detection of SARS-CoV-2 and other respiratory pathogens
- Closed, cartridge-based system that integrates extraction, amplification and detection
- Minimal hands-on time with automated processing on the QIAstat-Dx platform
- Rapid turnaround to support timely clinical decision-making and patient management
- Standardized workflow suitable for hospital, emergency and reference laboratory settings
Brochures
Global QIAstat-Dx syndromic testing solutions and bloodstream infection portfolio
This product brochure showcases the global QIAstat-Dx® syndromic testing portfolio for rapid detection of infectious disease pathogens across multiple clinical syndromes. Discover how the system enables fast identification of respiratory, gastrointestinal, meningitis/encephalitis, and bloodstream infection targets, including key antimicrobial resistance markers. Discover the advantages of one-step sample processing, multiplex RT-PCR technology, integrated cloud connectivity through QIAsphere®, and epidemiological monitoring tools that help laboratories support diagnostic and antimicrobial stewardship initiatives.
Resource details:
Resource type: Product brochure
Page count: 20
Read time: 15 min
U.S. FDA-cleared QIAstat-Dx syndromic testing solutions
This product brochure introduces the QIAstat-Dx® syndromic testing portfolio, highlighting rapid multiplex PCR solutions for respiratory, gastrointestinal, meningitis/encephalitis, and bloodstream infections. Discover how the platform delivers comprehensive pathogen detection, antimicrobial resistance insights, and clinical context from a single sample with minimal hands-on time. Explore the benefits of integrated connectivity, epidemiology monitoring through QIAsphere®, and flexible instrument configurations that support faster diagnosis, improved infection control, and more informed treatment decisions.
Resource details:
Resource type: Product brochure
Page count: 20
Read time: 15 mins
